ABSTRACT: A case of subacute progressive spinal tetraparesis had myelographic evidence of cervical spinal cord swelling and a delayed metrizamide computed tomographic myelogram (MCTM) suggested cavitation within the swollen spinal cord. Surgical exploration of the cervical cord revealed inflammatory changes only. No syrinx or intramedullary tumour was found. The accumulation of metrizamide within the spinal cord, as demonstrated by MCTM, did not'respresent a syrinx or a cystic tumour, but more likely an area of inflammation. Because inflammatory myelopathy may simulate an intramedullary tumor or syrinx, careful analysis of all clinical and radiological information is necessary to help make a correct diagnosis. RESUME: Dans un cas de quadripar£sie progressive subaigue, la mydlographie ar£v£16 un eMargissementde la moelle cervicale, et la tomographic axiale une cavity intraspinale 6tag6e correspondante. L'exploration chirurgicale n'a permis de documenter que des changements inflammatoires. Contrairement a ce que l'accumulation segmentaire du Metrizamide avait laiss6 suspecter, ni syrinx, ni tumeur intraspinale n'a €l6 retrouve\ La myelopathic inflammatoire pouvant simuler une tumeur ou une cavit£ syringomyeMique, son diagnostic presuppose une analyse encore plus rigoureuse des donn£es cliniques et radiologiques.
In the past decade, metrizamide myelography has become an important procedure for diagnosing spinal cord abnormalities. Recently, better definition of cord pathology has been obtained by metrizamide computed tomographic myelography (MCTM). In this procedure the spinal cord is scanned by computed tomography following an intrathecal injection of metrizamide.
A fusiform swelling of the spinal cord, as demonstrated by myelography, usually is associated with an intramedullary tumour or syrinx. Computed tomography may help distinguish tumour from syrinx. Following an intravenous injection of contrast agent, a spinal cord tumour should enhance on the CT scan and a syrinx should remain as a low density lesion. When metrizamide is injected intrathecally, a syrinx will gradually fill with metrizamide and will appear as a high density lesion within the spinal cord on the metrizamide computed tomographic myelogram. However, a cystic spinal cord tumour rarely may also accumulate metrizamide.
We have recently managed a patient with an inflammatory myelopathy whose MCTM revealed a metrizamide-filled lesion within a swollen spinal cord. This was thought to represent a syrinx or a cystic tumour (Bonafe et al., 1980; Winkler and Sackett, 1980) and she underwent exploration of her cervical spinal cord.
CASE HISTORY
A 31 year old Portugese woman was admitted to St. Michael's Hospital on October 6, 1982 for investigation of right arm and leg weakness and bilateral paresthesia. She was in good health until two months earlier when she developed a burning neck pain over a two day period. This burning pain radiated into both shoulders with neck flexion. One week later, she developed numbness in both arms and weakness of the right arm. Over the next week, the numbness extended into the right trunk and leg, and the right leg became weak. A myelogram, performed in another hospital, was reported to be normal. However, the motor and sensory symptoms progressed during the next two weeks and she was admitted to hospital for further investigation. She complained of severe burning neck pain which radiated as shocks into the right arm and hand. She found walking difficult and all four extremities felt numb.
She had malaria and rheumatic fever many years earlier and cholecystectomy, hysterectomy and splenectomy had been performed during the last few years.
Physical examination revealed findings of a cervical cord lesion. The cranial nerve examination was normal. She had severe weakness of her proximal right upper extremity and moderate weakness of that hand. The right leg was mildly weak. There was impaired pain and touch sensation in the right upper extremity, trunk and lower extremity. The lower limbs were hyper reflexic and Babinski signs were present bilaterally. During the next five days, the right upper extremity developed a flaccid paralysis, the left hand became paretic and she became bedridden THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES because of proximal leg weakness bilaterally. Because of urinary retention, catheterization was necessary.
A pantopaque myelogram showed the cervical spinal cord to have fusiform swelling from C2 to C6 suggesting the presence of an intramedullary lesion (figure 1). In the C4-C5 region, the cord appeared to occupy more than 80 per cent of the spinal canal. Cerebrospinal fluid analysis showed 6 lymphocytes/ml, a slightly elevated protein content (5.3 mg/1) and a normal sugar value. The gammaglobulin content was elevated.
A metrizamide computed tomographic myelogram was performed using 10 ml (170 mg iodine/ml) metrizamide. Delayed films of 8 and 12 hours showed an abnormally fat spinal cord from C2 to C6 and, in addition, revealed accumulation of metrizamide with the cord in the C5-C6 region (figure 2). An intramedullary lesion, either syrinx or cystic tumour, was diagnosed.
The cervical spinal cord was explored after performing an extensive cervical laminectomy. When the dura was opened, the cord appeared discoloured and swollen from C2 to C7, but no specific lesion was seen on its surface. Multiple needle aspirations yielded no fluid and biopsies revealed only inflammatory changes.
During the postoperative period, her neurological condition steadily improved. Because we suspected demyelination after the biopsies were reported negative for neoplasia, she was given prednisone 60 mg daily. Within three weeks she was free of neck pain, walking without aid and completely off steroids. The right hand had useful function and bladder function was normal.
Improvement continued for another six days, when she noticed that her walking had deteriorated, her right hand was clumsy, and urinary retention returned. Examination revealed that the power in the right upper limb and both legs had deteriorated. Cerebropsinal fluid analysis showed a mild elevation of lymphocytes and protein. Recurrence of the inflammatory myelitis was suspected and steroids were again administered. As before, marked improvement occurred over a 3-4 week period.
The clinical history and findings were felt to be compatible with inflammatory myelopathy, most likely secondary to demyelination of multiple sclerosis. 
DISCUSSION

Metrizamide computed tomographic myelography was introduced by DiChiro and Schellinger (1976). This procedure provides important visualization of the morphology of the spinal cord and allows dynamic study of cerebrospinal fluid pathways.
When metrizamide myelography demonstrates a fusiform swelling of the spinal cord, the diagnosis of an intramedullary mass such as a tumour or syrinx should be suspected. Although the specific diagnosis may remain uncertain until the lesion is surgically explored, a number of radiological distinguishing features may be seen. The "collapsing cord sign" on myelography is pathognomonic of syringomyelia. A contrast-enchanced CT-scan may demonstrate tumour tissue, but a syrinx will remain a low density lesion. A MCTM will further help to distinguish syrinx from tumour. After metrizamide is injected into the subarachnoid space, metrizamide will accumulate in the cyst during the immediate scan or later on a delayed scan. It must be remembered, however, that a cyst occasionally may be associated with an intramedullary tumour and rarely may also accumulate metrizamide.
Although syrinx and tumour are the most common causes of spinal cord swelling, a recent report described three cases of inflammatory myelopathy secondary to multiple sclerosis that had myelographic evidence of spinal cord swelling (Feasby et al., 1981) . The authors suggest that other investigations such as cerebrospinal fluid protein electrophoresis, evoked potentials, and CT scanning may be necessary to make a correct diagnosis of cord swelling.
Opacification of a well defined, initially low density region in a swollen spinal cord following an intrathecal injection of metrizamide is good evidence of syringomyelia. The mechanism by which the metrizamide fills the syrinx is poorly understood. 
